BMRN
BioMarin Pharmaceutical Inc. · Healthcare
CEO Jean Jacques Bienaime sold $798K of BioMarin Pharmaceutical Inc.
Sold$797,520
$88.61Price
9,000Shares
−2%Stake
What BMRN did after the filing
Prices for BMRN after this filing aren't in yet.
Traded Fri, May 1. Filed Tue, May 5, 7:22 PM ET, after the close. Not investment advice.